These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30604914)

  • 1. The 1st WFH Gene Therapy Round Table: Understanding the landscape and challenges of gene therapy for haemophilia around the world.
    Pierce GF; Coffin D;
    Haemophilia; 2019 Mar; 25(2):189-194. PubMed ID: 30604914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards a global multidisciplinary consensus framework on haemophilia gene therapy: Report of the 2nd World Federation of Haemophilia Gene Therapy Round Table.
    Pierce GF; Pasi KJ; Coffin D; Kaczmarek R; Lillicrap D; Mahlangu J; Rottellini D; Sannié T; Srivastava A; VandenDriessche T; Weill A;
    Haemophilia; 2020 May; 26(3):443-449. PubMed ID: 32202382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemophilia: provision of factors and novel therapies: World Federation of Hemophilia goals and achievements.
    Skinner MW
    Br J Haematol; 2011 Sep; 154(6):704-14. PubMed ID: 21707577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The World Federation of Hemophilia and research.
    Lillicrap D
    Haemophilia; 2012 Jul; 18 Suppl 4():24-7. PubMed ID: 22726078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. World Federation of Haemophilia programs in developing countries.
    Giangrande PL; Black C
    Semin Thromb Hemost; 2005 Nov; 31(5):555-60. PubMed ID: 16276464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Core outcome set for gene therapy in haemophilia: Results of the coreHEM multistakeholder project.
    Iorio A; Skinner MW; Clearfield E; Messner D; Pierce GF; Witkop M; Tunis S;
    Haemophilia; 2018 Jul; 24(4):e167-e172. PubMed ID: 29781145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Joint WFH-ISTH session: issues in clinical trial design.
    Peyvandi F; Farrugia A; Iorio A; Key NS; Srivastava A
    Haemophilia; 2014 May; 20 Suppl 4():137-44. PubMed ID: 24762289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment for all: a vision for the future.
    Skinner MW
    Haemophilia; 2006 Jul; 12 Suppl 3():169-73. PubMed ID: 16684013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MASAC Consensus Conference: impediments to conducting clinical research in persons with haemophilia, von Willebrand's disease and rare bleeding disorders.
    Koerper MA; Frick N; Kessler CM
    Haemophilia; 2013 Mar; 19(2):188-93. PubMed ID: 23051635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The World Federation of Hemophilia: 40 years of improving haemophilia care worldwide.
    Jones P; Robillard L
    Haemophilia; 2003 Nov; 9(6):663-9. PubMed ID: 14750930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Home therapy for inherited bleeding disorders in South Africa: Results of a modified Delphi consensus process.
    Mahlangu JN; Naidoo Y; Goga Y; Vaithlingum M; Joubert J; Sutton C; Potgieter J; Cruickshank AL; Iorio A
    S Afr Med J; 2019 Aug; 109(9):639-644. PubMed ID: 31635587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WFH: back to the future.
    O'Mahony B
    Haemophilia; 2004 Oct; 10 Suppl 4():1-8. PubMed ID: 15479364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pfizer-sponsored satellite symposium at the European Haemophilia Consortium (EHC) Congress: changing the policy landscape: haemophilia patient involvement in healthcare decision-making.
    O'Mahony B; Kent A; Aymé S
    Eur J Haematol Suppl; 2014 Jun; (74):1-8. PubMed ID: 24801295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The critical need for postmarketing surveillance in gene therapy for haemophilia.
    Konkle BA; Recht M; Hilger A; Marks P
    Haemophilia; 2021 Feb; 27 Suppl 3():126-131. PubMed ID: 32495492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Core data set on safety, efficacy, and durability of hemophilia gene therapy for a global registry: Communication from the SSC of the ISTH.
    Konkle B; Pierce G; Coffin D; Naccache M; Clark RC; George L; Iorio A; O'Mahony B; Pipe S; Skinner M; Watson C; Peyvandi F; Mahlangu J;
    J Thromb Haemost; 2020 Nov; 18(11):3074-3077. PubMed ID: 33463024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common themes and challenges in hemophilia care: a multinational perspective.
    Stoffman J; Andersson NG; Branchford B; Batt K; D'Oiron R; Escuriola Ettingshausen C; Hart DP; Jiménez Yuste V; Kavakli K; Mancuso ME; Nogami K; Ramírez C; Wu R
    Hematology; 2019 Dec; 24(1):39-48. PubMed ID: 30073913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WFH: closing the global gap--achieving optimal care.
    Skinner MW
    Haemophilia; 2012 Jul; 18 Suppl 4():1-12. PubMed ID: 22726075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partnering to change the world for people with haemophilia: 7th Haemophilia Global Summit, Madrid, Spain 22-24 September 2016.
    Dolan G
    Eur J Haematol; 2017 Oct; 99 Suppl 87():3-9. PubMed ID: 28921738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theory of change and strategic priorities of the world federation of haemophilia.
    Laliberté J; Coffin D; Haffar A; Mekhuzla S; Pierce GF; Flynn B; Márquez CS; Hermans C; Garrido C; Baumann A
    Haemophilia; 2023 Jan; 29(1):45-50. PubMed ID: 36222220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards achieving global haemophilia care--World Federation of Hemophilia programmes.
    Lee CA
    Haemophilia; 1998 Jul; 4(4):463-73. PubMed ID: 9873776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.